Partner at Innosight and healthcare consulting practice leader. Work with clients to design new strategies for long-term growth, architect resource allocation, build innovation capabilities, define new operating models, and manage enterprise-wide transformation. Significant M&A advisory experience, from initial identification, to transaction support, to post-merger integration.Served executive teams of leading companies across the healthcare value chain, including payors, providers, medical device, pharma / biotech, suppliers, and health information technology. Recent work has focused on how payors and providers can better collaborate to catalyze new care delivery models, new economic models, and better consumer experiences – both physical and digital.Beyond healthcare, served the leadership of global companies across a range of industries, including Automotive, Defense, and Energy. Efforts have centered on how cyclical, capital intensive firms can evolve their core business models and drive new growth simultaneously.Prior to joining Innosight, worked in the Health and Life Sciences practice of Oliver Wyman, developing product and portfolio strategies for bio-pharma clients and worked with leading health insurance companies to catalyze business model transformation, from fee-for-service to fee-for-value constructs. Before Oliver Wyman, advised a senior executive group at Genzyme, a leading biotech company headquartered in Cambridge, MA. Earlier, lead a team developing healthcare delivery integration strategies while at ICF International, a management consulting firm in Washington, D.C. Also leveraged past experience in public health, working with governments and non-profit foundations to develop strategies that increase outcomes, affordability and access.